Amphastar Pharmaceuticals (AMPH) Inventory (2016 - 2026)
Amphastar Pharmaceuticals has reported Inventory over the past 13 years, most recently at $176.9 million for Q4 2025.
- For Q4 2025, Inventory rose 15.06% year-over-year to $176.9 million; the TTM value through Dec 2025 reached $176.9 million, up 15.06%, while the annual FY2025 figure was $176.9 million, 15.06% up from the prior year.
- Inventory for Q4 2025 was $176.9 million at Amphastar Pharmaceuticals, down from $185.9 million in the prior quarter.
- Over five years, Inventory peaked at $191.7 million in Q2 2025 and troughed at $92.8 million in Q4 2021.
- A 5-year average of $123.7 million and a median of $105.2 million in 2023 define the central range for Inventory.
- Biggest five-year swings in Inventory: dropped 10.0% in 2021 and later soared 60.59% in 2025.
- Year by year, Inventory stood at $92.8 million in 2021, then grew by 11.61% to $103.6 million in 2022, then rose by 2.17% to $105.8 million in 2023, then surged by 45.27% to $153.7 million in 2024, then grew by 15.06% to $176.9 million in 2025.
- Business Quant data shows Inventory for AMPH at $176.9 million in Q4 2025, $185.9 million in Q3 2025, and $191.7 million in Q2 2025.